These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21727126)

  • 1. The evolving biology of small molecules: controlling cell fate and identity.
    Efe JA; Ding S
    Philos Trans R Soc Lond B Biol Sci; 2011 Aug; 366(1575):2208-21. PubMed ID: 21727126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
    Li W; Ding S
    Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development unchained: how cellular reprogramming is redefining our view of cell fate and identity.
    Efe JA; Yuan X; Jiang K; Ding S
    Sci Prog; 2011; 94(Pt 3):298-322. PubMed ID: 22026150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering small molecules to control stem cell fate.
    Andrews PD
    Future Med Chem; 2011 Sep; 3(12):1539-49. PubMed ID: 21882946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of stem cell pluripotency and differentiation by G protein coupled receptors.
    Callihan P; Mumaw J; Machacek DW; Stice SL; Hooks SB
    Pharmacol Ther; 2011 Mar; 129(3):290-306. PubMed ID: 21073897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA in pluripotent stem cells.
    Lakshmipathy U; Davila J; Hart RP
    Regen Med; 2010 Jul; 5(4):545-55. PubMed ID: 20632858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical reprogramming for cell fate manipulation: Methods, applications, and perspectives.
    Wang J; Sun S; Deng H
    Cell Stem Cell; 2023 Sep; 30(9):1130-1147. PubMed ID: 37625410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of embryonic stem cell fate and somatic cell reprogramming by small molecules.
    Zhang XZ
    Reprod Biomed Online; 2010 Jul; 21(1):26-36. PubMed ID: 20462797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNAs in the Regulation of Pluripotency and Reprogramming.
    Sherstyuk VV; Medvedev SP; Zakian SM
    Stem Cell Rev Rep; 2018 Feb; 14(1):58-70. PubMed ID: 29143182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in pluripotency, reprogramming and cell fate induction.
    Lüningschrör P; Hauser S; Kaltschmidt B; Kaltschmidt C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1894-903. PubMed ID: 23557785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecules in cellular reprogramming and differentiation.
    Yuan X; Li W; Ding S
    Prog Drug Res; 2011; 67():253-66. PubMed ID: 21141734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory circuits underlying pluripotency and reprogramming.
    Do JT; Schöler HR
    Trends Pharmacol Sci; 2009 Jun; 30(6):296-302. PubMed ID: 19427042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmable genetic switches to control transcriptional machinery of pluripotency.
    Pandian GN; Sugiyama H
    Biotechnol J; 2012 Jun; 7(6):798-809. PubMed ID: 22588775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
    Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
    Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotency of mouse and human somatic cells.
    Maherali N; Hochedlinger K
    Cold Spring Harb Symp Quant Biol; 2008; 73():157-62. PubMed ID: 19022751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upping the ante: recent advances in direct reprogramming.
    Müller LU; Daley GQ; Williams DA
    Mol Ther; 2009 Jun; 17(6):947-53. PubMed ID: 19337233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capturing the ephemeral human pluripotent state.
    Ávila-González D; García-López G; García-Castro IL; Flores-Herrera H; Molina-Hernández A; Portillo W; Díaz NF
    Dev Dyn; 2016 Jul; 245(7):762-73. PubMed ID: 27004967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pluripotency and reprogramming by transcription factors.
    Pei D
    J Biol Chem; 2009 Feb; 284(6):3365-9. PubMed ID: 18819918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic landscape of pluripotent stem cells.
    Han JW; Yoon YS
    Antioxid Redox Signal; 2012 Jul; 17(2):205-23. PubMed ID: 22044221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell fate conversion-from the viewpoint of small molecules and lineage specifiers.
    Zhao T; Li Y; Deng H
    Diabetes Obes Metab; 2016 Sep; 18 Suppl 1():3-9. PubMed ID: 27615126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.